Stocks › CELC
Celcuity Inc.
CELC·Nasdaq·
United States·USD
$71.25
-2.37 (-3.22%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CELC
Celcuity Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CELCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CELC by members of U.S. Congress · 4 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Tom MalinowskiHouse · D · NJ |
CELCCelcuity Inc. · Stock |
Purchase $1,001 - $15,000 |
Aug 26, 2021 | Jun 23, 2020 | Filing ↗ |
Tom MalinowskiHouse · D · NJ |
CELCCelcuity Inc. · Stock |
Purchase $1,001 - $15,000 |
Aug 26, 2021 | Jun 22, 2020 | Filing ↗ |
Tom MalinowskiHouse · D · NJ |
CELCCelcuity Inc. · Stock |
Sale $1,001 - $15,000 |
Jun 23, 2021 | May 26, 2021 | Filing ↗ |
Tom MalinowskiHouse · D · NJ |
CELCCelcuity Inc. · Stock |
Purchase $1,001 - $15,000 |
Mar 5, 2021 | Jun 18, 2020 | Filing ↗ |
Whale Activity
Position changes in CELC reported for 2026-09-30 by 1 tracked institutional filer
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| Acasta Partners UK LLP | 2.0M | $3.6M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CELC insiders, by quarter · Form 4
Recent Insider Transactions
131 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN | Sale | −2.8M | n/c | — | Jul 14, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX / BAKER JULIAN | Sale | −261.4K | $102.50 | $26.8M | Jul 14, 2026 | Form 4 ↗ |
| Murphy Polly A.Director | Grant / award | +1,530 | $0.00 | $0 | Jun 5, 2026 | Form 4 ↗ |
| ROMP CHARLES RDirector | Grant / award | +1,530 | $0.00 | $0 | Jun 5, 2026 | Form 4 ↗ |
| Furcht LeoDirector | Grant / award | +1,530 | $0.00 | $0 | Jun 5, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Grant / award | +1,530 | $0.00 | $0 | Jun 5, 2026 | Form 4 ↗ |
| Dalvey DavidDirector | Grant / award | +1,530 | $0.00 | $0 | Jun 5, 2026 | Form 4 ↗ |
| NIGON RICHARDDirector | Grant / award | +1,530 | $0.00 | $0 | Jun 5, 2026 | Form 4 ↗ |
| Laing Lance G.Chief Science Officer · Director | Option exercise | +1,000 | $9.89 | $10K | Jun 2, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Gift | +1,029 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Gift | −1,029 | $0.00 | $0 | May 19, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Sale | −365 | $143.24 | $52K | May 4, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Sale | −2,825 | $142.04 | $401K | May 4, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Sale | −2,301 | $141.03 | $325K | May 4, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Sale | −1,670 | $139.58 | $233K | May 4, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Sale | −550 | $139.00 | $76K | May 4, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Sale | −1,289 | $137.00 | $177K | May 4, 2026 | Form 4 ↗ |
| Buller Richard EDirector | Option exercise | +9,000 | $5.10 | $46K | May 4, 2026 | Form 4 ↗ |
| Dalvey DavidDirector | Sale | −25.0K | $140.68 | $3.5M | May 4, 2026 | Form 4 ↗ |
| NIGON RICHARDDirector | Gift | −10.0K | $0.00 | $0 | Apr 9, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CELC · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.4M | $145.8M | 0.01% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.1M | $118.0M | 1.10% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 987.7K | $103.3M | 0.12% | Jun 30, 2026 |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 375.6K | $49.9M | 0.95% | May 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 436.2K | $45.6M | 0.05% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 355.2K | $37.2M | 0.24% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH Capitol Series Trust | 350.0K | $36.6M | 0.59% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 420.6K | $36.3M | 0.11% | Jul 31, 2026 |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 289.5K | $30.3M | 0.31% | Jun 30, 2026 |
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 286.2K | $29.9M | 1.18% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list CELC's shares (CUSIP 15102K100), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- BANK OF AMERICA CORP /DE/SCHEDULE 13G · passive (13G) · 3.2M shares6.5%
Aug 11, 2026 · ↗ - Felix J. BakerSCHEDULE 13G · passive (13G) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Julian C. BakerSCHEDULE 13G · passive (13G) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Baker Bros. Advisors (GP) LLCSCHEDULE 13G · passive (13G) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Baker Bros. Advisors LPSCHEDULE 13G · passive (13G) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Felix J. BakerSCHEDULE 13D/A · activist (13D) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Julian C. BakerSCHEDULE 13D/A · activist (13D) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Baker Bros. Advisors (GP) LLCSCHEDULE 13D/A · activist (13D) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Baker Bros. Advisors LPSCHEDULE 13D/A · activist (13D) · 4.9M shares10.0%
Jul 16, 2026 · ↗ - Roderick WongSCHEDULE 13G · passive (13G) · 3.0M shares6.3%
May 15, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Celcuity Inc. as client
No lobbying filings found naming Celcuity Inc. as the client.
Government Contracts
Federal awards to Celcuity Inc. · USAspending
No federal contract awards found for Celcuity Inc..
U.S. Patents
Recent USPTO applications naming Celcuity Inc.
No USPTO patent applications found for Celcuity Inc..
Annual Financials
From CELC's 10-K filings · XBRL
No annual XBRL figures on record for CELC. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CELC's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureOct 2, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsSep 30, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsAug 26, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 13, 2026
EDGAR ↗ - 8-K/A · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsJul 15, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsJul 15, 2026
EDGAR ↗ - 8-K · Items 1.01, 1.02, 2.03, 8.01, 9.01Material agreement · Termination of agreement · Direct financial obligationJun 8, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsJun 2, 2026
EDGAR ↗ - 8-K/A · Items 5.02Officer / director changeMay 20, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteMay 18, 2026
EDGAR ↗
About Celcuity Inc.
From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersMINNEAPOLIS, MN
IncorporatedDE
SEC CIK0001603454 ↗
Former namesCelcuity LLC

